StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Dicyclohexylcarbodiimide → t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside

HRID 628195
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 628195
[CH2:1]([O:8][C@H:9]([CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[CH2:10][C:11]([OH:13])=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1CCC(N=C=NC2CCCCC2)CC1.[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:72]=[CH:71][CH:70]=[CH:69][CH:68]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:87])([CH3:86])[CH3:85])([CH3:83])[CH3:82])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77](O)[C@@H:76]2[O:93][CH2:94][C:95]2[CH:100]=[CH:99][CH:98]=[CH:97][CH:96]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]>C(Cl)Cl.CN(C1C=CN=CC=1)C>[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:68]=[CH:69][CH:70]=[CH:71][CH:72]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:85])([CH3:87])[CH3:86])([CH3:82])[CH3:83])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77]([O:12][C:11](=[O:13])[CH2:10][C@H:9]([O:8][CH2:1][C:2]3[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=3)[CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[C@@H:76]2[O:93][CH2:94][C:95]2[CH:96]=[CH:97][CH:98]=[CH:99][CH:100]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 10868DicyclohexylcarbodiimideHCID 16216230t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-2-deoxy-beta-D-glucopyranosideHCID 67004404(r)-3-Benzyloxy-dodecanoic acid

Produkt 1

HCID 87233474
t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside
Ausbeute 91 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 142844-(Dimethylamino)pyridineKatalysatorHCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

A solution of (R)-3-benzyloxy-dodecanoic acid 14 (86 mg, 0.281 mmol) and DCC (78 mg, 0.376 mmol) in DCM (5 mL) was stirred at room temperature for 10 min, and then disaccharide 21 (250 mg, 0.188 mmol) in DCM (2 mL) and DMAP (11 mg, 0.094 mmol) were added. The reaction mixture was stirred for another 14 h, after which the solids were removed by filtration, and the residue was washed with DCM (2×1 mL). The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1, v/v) to give 36 as a white solid (277 mg, 91%). Rf=0.41 (hexane/ethyl acetate, 2/1, v/v). [α]26D=−3.0° (c=1.0, CHCl3). 1H NMR (600 MHz, CDCl3): δ 7.34-7.15 (m, 19H, aromatic), 6.01 (d, 1H, JNH′,2=7.2 Hz, NH′), 5.92-6.86 (m, 1H, OCH2CH═CH2), 5.46 (t, 1H, J2′,3′=J3′,4′=9.6 Hz, H-3′), 5.34 (d, 1H, J=16.8 Hz, OCH2CH═CH2), 5.22 (d, 1H, J=10.8 Hz, OCH2CH═CH2), 5.08-4.97 (m, 7H, H-1′, H-3, H-3L, C6H4(CH2O)2P), 4.61-4.45 (m, 10H, H-1, H-4′, 3×CH2Ph, OCH2CH═CH2), 3.97 (d, 1H, J6′a,6′b=10.5 Hz, H-6′a), 3.88-3.86 (m, 1H, H-3S), 3.81 (d, 1H, J6a,6b=9.5 Hz, H-6a), 3.73-3.68 (m, 3H, H-5′, H-6b, H-6′b), 3.56-3.46 (m, 3H, H-2′, H-4, H-5), 3.28 (dd, 1H, J1,2=7.8 Hz, J2,3=10.2 Hz, H-2), 2.56 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sa,3S=7.2 Hz, H-2Sa), 2.44 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sb,S3=6.0 Hz, H-2Sb), 2.36 (dd, 1H, J2La,2Lb=15.0 Hz, J2La,3 L=6.0 Hz, H-2La), 2.30-2.21 (m, 3H, H-2L′, H-2L′b), 1.57-1.53 (m, 6H, H-4L, H-4S, H-3L′), 1.24 (broad, 48H, 24×CH2, lipid), 0.90 (s, 9H, SiC(CH3)3), 0.89-0.85 (m, 9H, 3×CH3, lipid), 0.13 (s, 6H, Si(CH3)2). 13C NMR (75 MHz, CDCl3): δ 173.54 (C═O), 170.64 (C═O), 170.03 (C═O), 154.49 (C═O), 138.52-127.43 (aromatic, OCH2CH═CH2), 118.84 (OCH2CH═CH2), 99.34 (C-1′), 97.02 (C-1), 76.00, 75.70, 74.33, 74.08, 73.73, 73.48, 71.46, 71.01, 68.95-67.99 (m), 66.55, −4.13 (Si(CH3)2), −5.32 (Si(CH3)2). HR MS (m/z) calculated for C89H135N4O19PSi [M+Na], 1645.9125. found, 1646.2435.

Aufarbeitung

  1. customafter which the solids were removed by filtration
  2. washthe residue was washed with DCM (2×1 mL)
  3. concentrationThe combined filtrates were concentrated in vacuo
  4. customthe residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1

Quellen und Nachweise

ORD-Eintrag
ord-ca21e0a3ae64460a82af848b7d7c58ea
Quelldatensatz
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09309276B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion